These categories represent clinically distinct patient groups [13,14], and correspond to different breast tumor subtypes with respect to ER and TP53 mutation status: ER+ tumors are generally identified as luminal-like subtype [14], while tumors with TP53 mutations usually belong to the basal-like type [15]. Here, TP53 is linked to breast neoplasm.